MLS-573151

CAS No. 10179-57-4

MLS-573151 ( —— )

Catalog No. M23224 CAS No. 10179-57-4

MLS-573151 is a selective inhibitor of GTPase Cdc42(EC50 of 2 μM).

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 43 In Stock
5MG 72 In Stock
10MG 125 In Stock
25MG 260 In Stock
50MG 410 In Stock
100MG 605 In Stock
500MG 1287 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    MLS-573151
  • Note
    Research use only, not for human use.
  • Brief Description
    MLS-573151 is a selective inhibitor of GTPase Cdc42(EC50 of 2 μM).
  • Description
    MLS-573151 is a selective inhibitor of GTPase Cdc42(EC50 of 2 μM). It is inactive against other GTPases family members, such as Rab2, Rab7, H-Ras, Rac1, Rac 2 and RhoA wild-type. MLS-573151 acts by blocking the binding of GTP to Cdc42.
  • Synonyms
    ——
  • Pathway
    Angiogenesis
  • Target
    CDK
  • Recptor
    Cdc42
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    10179-57-4
  • Formula Weight
    377.5
  • Molecular Formula
    C21H19N3O2S
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:10 mM
  • SMILES
    C1C(N(N=C1C2=CC=CC=C2)C3=CC=C(C=C3)S(=O)(=O)N)C4=CC=CC=C4
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Fan Mao, et al. Transcriptomic Evidence Reveals the Molecular Basis for Functional Differentiation of Hemocytes in a Marine Invertebrate, Crassostrea gigas. Front Immunol. 2020 May 27;11:911.
molnova catalog
related products
  • CCT251545

    CCT251545 is a potent, orally bioavailable inhibitor of Wnt signaling with IC50 of 5 nM, also is a potent and selective chemical probe for CDK8 and CDK19 with >100-fold selectivity over 291 other kinases; potently inhibits reporter-based readouts of basal WNT pathway activity in LS174T and SW480 cells in the absence of WNT ligand with IC50 of 23 and 190 nM, respectively.

  • CYC065

    CYC065 is a derivative of seliciclib and second generation CDK inhibitor that is mainly active on CDK2/5/9.

  • LY2835219

    LY2835219 is a potent and selective inhibitor of CDK4 and CDK6 with IC50 of 2 nM and 10 nM, respectively.